key: cord-0977286-2neixoeo
authors: Wang, Pei
title: Recurrent presence of SARS‐CoV‐2 RNA in a 33‐year‐old man
date: 2020-07-28
journal: J Med Virol
DOI: 10.1002/jmv.26334
sha: 86bb49958fec7fc779167e133cb5aa329d56a624
doc_id: 977286
cord_uid: 2neixoeo

A 33- year-old man had four times recurrent presence of SARS-CoV-2 RNA after 137 days onset of illness, the presence of antibodies did not prevent recurrent infections, but maybe inhibited transmission. This case could have implications for the properties of future vaccines. Reasons for the repeated presence of SARS-CoV-2 RNA may be contribute to the biological characteristics of SARS-CoV-2 and might also be related to coexisting diseases, low neutralizing antibody titres or resistance to antiviral drugs. This article is protected by copyright. All rights reserved.

To the Editor, Many studies have reported the potential human-to-human transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). 1 The patient stayed in the Infectious Disease Department until the RT-PCR test was negative for SARS-CoV-2. After discharge, the patient remained for 2 weeks in isolation in the Observation Department. Before release from this ward, the patient was tested by RT-PCR. When negative, the patient was allowed to go home. When positive, the patient was admitted again to the Infectious Disease Department. A negative RT-PCR result is requested of everyone before they return to work and study.

were positive on 16 March during the second episode. The total antibody test uses the receptor-binding protein of the virus as a coating antigen, and the test has high sensitivity and specificity.

During the third and the fourth episodes, the total antibody test was positive but no IgM was detected. These results show that in this particular case antibodies did not prevent the recurrent infections, but they may have inhibited transmission.

Reasons for the repeated presence of SARS-CoV-2 RNA may arise from the biological characteristics of SARS-CoV-2 and might also be related to coexisting diseases. 5 It remains unknown whether SARS-CoV-2 antibody formation confers immunity; perhaps low titers of neutralizing antibody did not result in protective immunity to SARS-CoV-2. Another possible explanation for the repeated presence of SARS-CoV-2 RNA is inducible resistance to antiviral drugs.

In an interview, the patient stated that he did not take antiviral drugs regularly after discharge from the hospital because he was afraid that his liver function would be injured as a side effect.

Studying a larger group of cases over a prolonged period should provide information on whether the presented case is exceptional or common, which could have implication for the properties of future vaccines.

The author declares that there are no conflict of interests.

All data generated or analyzed during this study are included in this article.

Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia

Transmission of 2019-nCoV infection from an asymptomatic contact in Germany

Combination of serological total antibody and RT-PCR test for detection of SARS-CoV-2 infections

Understanding COVID-19: what does viral RNA load really mean?

SARS-CoV-2 positivity in a discharged COVID-19 patient: a case report